18 February 2008
Medical insurance restricting access to clopidogrel can delay or stop patients receiving treatment with the drug after percutaneous coronary intervention with stenting, which in turn may increase their risk for dying, a Canadian study suggests.
Medwire News: Restricted clopidogrel access linked to increased mortality after PCI
No comments:
Post a Comment